Literature DB >> 10542991

Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology.

J A Jacobs1, E I De Brauwer, G Ramsay, N A Cobben, S S Wagenaar, A J van der Ven, C A Bruggeman, M Drent.   

Abstract

The present study investigated the usefulness of bronchoalveolar (BAL) fluid cytology in the identification of non-infectious pulmonary conditions in patients hospitalized in the intensive care unit (ICU) and suspected of pneumonia. A total of 182 BAL fluid samples obtained during a 27-month period from 130 ICU patients with suspected pneumonia were quantitatively cultured and investigated for opportunistic pathogens. Cytocentrifuged preparations stained with the May-Grünwald Giemsa and Perls's methods were reviewed. A non-infectious aetiology was considered when cultures yielded micro-organisms in quantities < 10(3) colony-forming units (CFU) per ml, in the absence of any other pathogen and in conjunction with one or more of the following cytological findings: > 20% haemosiderin macrophages, > 10% lymphocytes, the presence of activated lymphocytes, plasma cells, > 5% eosinophils, a preponderance of foamy macrophages, reactive type II pneumocytes or malignant cells. Patients' clinical records were reviewed to identify a clinical diagnosis for these episodes. In thirty-five (19.2%) BAL fluid samples from 26 patients, the cytological findings pointed to a non-infectious origin. An alternative diagnosis was ascertained in 20 of 26 patients. Diagnoses included: drug-induced pneumonitis (n = 7), aspiration of gastric contents (n = 2), pulmonary emboli (n = 3), adult respiratory distress syndrome (n = 4), lung contusion (n = 1), cardiogenic pulmonary oedema (n = 1), and carcinomatous lymphangitis (n = 2). The BAL fluid cytological findings were readily discernable and proved to be useful in the diagnostic work-up of samples obtained from ICU patients with suspected pneumonia.

Entities:  

Mesh:

Year:  1999        PMID: 10542991     DOI: 10.1016/s0954-6111(99)90157-9

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Accuracy and precision of quantitative calibrated loops in transfer of bronchoalveolar lavage fluid.

Authors:  J A Jacobs; E I De Brauwer; E I Cornelissen; M Drent
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Phaeohyphomycosis caused by Alternaria infectoria in a renal transplant recipient.

Authors:  T Halaby; H Boots; A Vermeulen; A van der Ven; H Beguin; H van Hooff; J Jacobs
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

3.  Influence of antibiotic therapy on the cytological diagnosis of ventilator-associated pneumonia.

Authors:  Catharina F M Linssen; Jan A Jacobs; Jan S A G Schouten; Walther N K A van Mook; Graham Ramsay; Marjolein Drent
Journal:  Intensive Care Med       Date:  2008-02-05       Impact factor: 17.440

4.  Clara cell protein in bronchoalveolar lavage fluid: a predictor of ventilator-associated pneumonia?

Authors:  Marijke J Vanspauwen; Catharina F M Linssen; Cathrien A Bruggeman; Jan A Jacobs; Marjolein Drent; Dennis C J J Bergmans; Walther N K A van Mook
Journal:  Crit Care       Date:  2011-01-11       Impact factor: 9.097

5.  Bronchoalveolar lavage cytological alveolar damage in patients with severe pneumonia.

Authors:  Bogdan Grigoriu; Frédéric Jacobs; Fabienne Beuzen; Rony El Khoury; Olivier Axler; Francois G Brivet; Frédérique Capron
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

Review 6.  The role of eosinophils in sepsis and acute respiratory distress syndrome: a scoping review.

Authors:  Zainab Al Duhailib; Malik Farooqi; Joshua Piticaru; Waleed Alhazzani; Parameswaran Nair
Journal:  Can J Anaesth       Date:  2021-01-25       Impact factor: 6.713

7.  Neutrophils and secondary infections in COVID-19 induced acute respiratory distress syndrome.

Authors:  Z M Holliday; M M Alnijoumi; M A Reed; A P Earhart; A G Schrum; L-A H Allen; A Krvavac
Journal:  New Microbes New Infect       Date:  2021-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.